Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
Product Classification
Formulation Information
MOUTHWASH
**How to use this medicine?** Difflam®-C Solution should generally be used undiluted, but if stinging occurs it may be diluted with water. The solution should be expelled from the mouth after use. Uninterrupted treatment should not exceed seven days. **Adults** When used as a gargle, 15mL should be gargled for at least 30 seconds at 1½ to 3 hourly intervals, as needed. When used as a rinse for oral lesions, 15mL should be held in the mouth and swished around for at least 30 seconds. Repeat usage every 1½ to 3 hours throughout the day. If used as an alternative to usual oral hygiene procedures, Difflam®-C Solution should be swished around in the mouth for at least a minute. Difflam®-C Solution is best used after brushing the teeth to minimise chlorhexidine-induced discolouration. Difflam®-C Solution is not intended for prolonged use except under dental or medical supervision. **Children** 5–15mL as a gargle if able to do so, or as an oral rinse. Difflam®-C Solution is not recommended for children under 6 years of age.
ORAL
Medical Information
**What is this medicine used for?** Benzydamine in Difflam®-C Solution helps to relieve painful conditions of the mouth and throat including sore throat, pharyngitis, tonsilitis, mouth ulcers, swelling, redness and inflammatory conditions, pain following mouth or throat surgery and pain following dental procedures. Chlorhexidine in Difflam®-C Solution helps to reduce the development of plaque and gingivitis during the period of treatment when the usual oral hygiene measures are interrupted. Difflam®-C is not intended for prolonged use except under dental or medical supervision.
**Do not use this medicine if** You are allergic to benzydamine or to any of the components of the product. Chlorhexidine may cause a severe allergic reaction. Symptoms of allergic reaction may include wheezing/difficulty breathing, facial swelling, hives, rash. If any allergic reaction occurs, stop use and seek medical help immediately.
A01AD02
benzydamine
Manufacturer Information
INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Ensign Laboratories Pty Ltd
Active Ingredients
Documents
Patient Information Leaflets
Difflam C Anti-Inflammatory Antiseptic Solution PIL.pdf
Approved: October 20, 2022